Anticoagulant Targeting the Hepatic Sinusoids for Liver Injury Following Orthotopic Liver Transplantation
针对原位肝移植后肝损伤的肝正弦抗凝剂
基本信息
- 批准号:07670611
- 负责人:
- 金额:$ 1.6万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1995
- 资助国家:日本
- 起止时间:1995 至 1996
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
In endothelial cells of the hepatic sinusoids, the expression of tissue factor pathway inhibitor (TFPI) and thrombomodulin, most important anticoagulant factors, are extremely decreased compared to those in peripheral blood vessels in other ortans. The present study was attempted to express exogenous TFPI and micelles carrying thrombomodulin gene selectively on hepatic sinusoidal walls for the treatment of liver injury following orthotopic liver transplantation (OLTX) in rats.When rats received recombinant human TFPI intravenously, it disappeared from the circulation rapidly after the injection, but was detected electron microscopically on the surface of sinusoidal endothelial cells and microvilli of hepatocytes in the space of Disse. In these rats, the TFPI reappeared in the plasma and disappeared from the hepatic sinusoidal walls by intravenous injection of heparin sodium. Polyvinyl sugar forms a micelle in water with sugar chains on the outside. This micelle can carry thrombomodulin … More cDNA coupled with SV40 virus promoter in its center. When such micelles containing mannose as sugar and FITC on the surface were injected via the portal vein in rats, fluorescent products were seen along the lining of sinusoidal walls, suggesting that the micelles were trapped by mannose receptors on the surface of sinusoidal walls. Thus, exogenous TFPI and micelles consisting of polyvinyl mannose and thrombomodulin cDNA would be available for the therapy of liver injury following OLTX where endothelial cells are markedly destroyed.In the treatment of sinusoidal fibrin deposition following OLTX,stimulation of proliferation of sinusoidal endothelial cells would be also desirable. Recently, we demonstrated that the proliferative process of sinusoidal endothelial cells may be regulated through VEGF produced by regenerating hepatocytes, activated Kupffer cells and hepatic stellate cells. Based on these results, we are now trying to devise a novel strategy for the treatment of sinusoidal fibrin deposition by regulating the expressions of VEGF and its receptors. Less
在肝窦内皮细胞中,最重要的抗凝因子组织因子途径抑制物(TFPI)和血栓调节蛋白的表达与其他器官的外周血管相比显著降低。本研究尝试在大鼠肝窦壁选择性表达外源性TFPI和携带血栓调节蛋白基因的胶束,用于治疗大鼠原位肝移植(OLTX)后的肝损伤。电镜下可见肝窦内皮细胞表面及肝细胞微绒毛。在这些大鼠中,TFPI重新出现在血浆中,并通过静脉注射肝素钠从肝窦壁消失。聚乙烯基糖在水中形成胶束,糖链在外面。这种胶束可以携带血栓调节蛋白 ...更多信息 其中心偶联有SV40病毒启动子的cDNA。将表面含糖甘露糖和FITC的胶束经门静脉注入大鼠肝窦后,可沿着窦壁内壁观察到荧光产物,提示胶束被窦壁表面的甘露糖受体捕获。因此,外源性TFPI和由聚乙烯甘露糖和血栓调节蛋白cDNA组成的胶束将可用于治疗OLTX后的肝损伤,其中内皮细胞被显著破坏。在治疗OLTX后的窦状隙纤维蛋白沉积时,刺激窦状隙内皮细胞的增殖也是期望的。最近,我们发现肝窦内皮细胞的增殖过程可能通过再生肝细胞、激活的枯否细胞和肝星状细胞产生的VEGF来调节。基于这些结果,我们现在正试图设计一种新的策略,通过调节VEGF及其受体的表达来治疗窦状隙纤维蛋白沉积。少
项目成果
期刊论文数量(42)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Fujiwara K,Mochida S,et al.: "Use of Prostaqlandin I2 analog in the treatment of massive hepatic necrosis associated with endothelial injury and diffuse sinusoidal Fibrin deposition." Dig Dis Sci. 40. 41-47 (1995)
Fujiwara K、Mochida S 等人:“使用 Prostaqlandin I2 类似物治疗与内皮损伤和弥漫性肝窦纤维蛋白沉积相关的大量肝坏死。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Arai M,Mochida S,Ohno A,Fujiwara K.: "Blood coagulation in the hepatic sinusoids as a factor of liver injury following orthotopic liver transplantation in rats." Transplantation. 62. 1398-1401 (1996)
Arai M、Mochida S、Ohno A、Fujiwara K.:“肝窦中的血液凝固是大鼠原位肝移植后肝损伤的一个因素。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Fujiwara K,Mochida S,et al.: "Use of Prostaglandin I2 analog in the treatment of massive hepatic necrosis associated with endothelial injury and diffuse sinusoidal tibrin deposition." Dig Dis Sci. 40. 41-47 (1995)
Fujiwara K、Mochida S 等人:“使用前列腺素 I2 类似物治疗与内皮损伤和弥漫性肝窦 tibrin 沉积相关的大量肝坏死。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Arai M,Mochida S,Ohno A,Fujiwara K.: "Blood coaqulation in the hepatic sinusoids as a factor of liver injury following orthotopic liver transplantation in rats." Transplantation. 62. 1398-1401 (1996)
Arai M、Mochida S、Ohno A、Fujiwara K.:“肝窦中的血液凝固是大鼠原位肝移植后肝损伤的一个因素。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Mochida S,Ohno A,Arai M,Tamatani T,Miyasaka M,Fujiwara K.: "Role of Adhesion Molecules in the Development of Massive Hepatic Necrosis in Rats" Hepatology. 23. 320-328 (1996)
Mochida S、Ohno A、Arai M、Tamatani T、Miyasaka M、Fujiwara K.:“粘附分子在大鼠大面积肝坏死发展中的作用”肝病学。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MOCHIDA Satoshi其他文献
MOCHIDA Satoshi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MOCHIDA Satoshi', 18)}}的其他基金
Identification of Female-Specific Transcriptional Factors for Osteopontin Translation as a Host Factor to Determine the Difference of Clinical Features of Liver Diseases between Male and Female Patients
鉴定女性特异性骨桥蛋白翻译转录因子作为宿主因子,以确定男性和女性患者肝病临床特征的差异
- 批准号:
21590858 - 财政年份:2009
- 资助金额:
$ 1.6万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The regulatory mechanisms of osteopontin expression in as a genetic factor to determine inflammatory grading in the liver of HCV infected patients
骨桥蛋白表达作为遗传因素决定HCV感染患者肝脏炎症分级的调节机制
- 批准号:
19590788 - 财政年份:2007
- 资助金额:
$ 1.6万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genetic factors determining the severity of hepatitis in patients receiving hepatitis virus infection : Significance of osteopontin promoter SNPs
决定肝炎病毒感染患者肝炎严重程度的遗传因素:骨桥蛋白启动子SNP的意义
- 批准号:
16590628 - 财政年份:2004
- 资助金额:
$ 1.6万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The significance of Osteopontin in development of necrosis, regeneration, fibrosis and carcinogenesis in the liver : Evaluation using osteopontin transgenic mice.
骨桥蛋白在肝脏坏死、再生、纤维化和癌变发展中的重要性:使用骨桥蛋白转基因小鼠进行评估。
- 批准号:
14570505 - 财政年份:2002
- 资助金额:
$ 1.6万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Role of Osteopontin in Macrophage Infiltration into Injured Liver.
骨桥蛋白在巨噬细胞浸润受损肝脏中的作用。
- 批准号:
11670529 - 财政年份:1999
- 资助金额:
$ 1.6万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Mechanisms of Impaired Liver Regeneration in Fulminant Hepatic Failure : The Significance of Sinusoidal Endothelial Cell Proliferation.
暴发性肝衰竭中肝脏再生受损的机制:正弦内皮细胞增殖的意义。
- 批准号:
09670571 - 财政年份:1997
- 资助金额:
$ 1.6万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Pluripotent stem cell derived hepatocytes for liver failure (PUSH for LIFE)
多能干细胞衍生的肝细胞治疗肝衰竭(PUSH for LIFE)
- 批准号:
MR/Z503940/1 - 财政年份:2024
- 资助金额:
$ 1.6万 - 项目类别:
Research Grant
Senescent hepatocytes mediate reprogramming of immune cells in acute liver failure
衰老肝细胞介导急性肝衰竭中免疫细胞的重编程
- 批准号:
10679938 - 财政年份:2023
- 资助金额:
$ 1.6万 - 项目类别:
I-Corps: Medical device to treat liver failure
I-Corps:治疗肝衰竭的医疗设备
- 批准号:
2348688 - 财政年份:2023
- 资助金额:
$ 1.6万 - 项目类别:
Standard Grant
Development of a Novel Liver Failure Therapy Based on Improvement of Energy Status of Hepatocytes by Oxygenated Perfusion
开发基于氧合灌注改善肝细胞能量状态的新型肝衰竭疗法
- 批准号:
23K08166 - 财政年份:2023
- 资助金额:
$ 1.6万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Novel regenerative therapy for liver failure with skeletal myoblast cell sheet transplantation
骨骼肌成肌细胞片移植治疗肝衰竭的新型再生疗法
- 批准号:
22K08800 - 财政年份:2022
- 资助金额:
$ 1.6万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Hepatocytes Encapsulated with mesenchymal stromal cells in alginate microbeads for the treatment of acute Liver failure in Paediatric patients (HELP)
将间充质基质细胞封装在藻酸盐微珠中的肝细胞用于治疗儿科患者的急性肝衰竭(HELP)
- 批准号:
MR/V038583/1 - 财政年份:2022
- 资助金额:
$ 1.6万 - 项目类别:
Research Grant
New treatment methods for liver failure by human iPS cells
人类iPS细胞治疗肝衰竭的新方法
- 批准号:
22K08735 - 财政年份:2022
- 资助金额:
$ 1.6万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Checkpoint Inhibitors to Restore Monocyte/Macrophage Function in Liver Failure
检查点抑制剂可恢复肝衰竭患者的单核细胞/巨噬细胞功能
- 批准号:
MR/W015412/1 - 财政年份:2022
- 资助金额:
$ 1.6万 - 项目类别:
Research Grant
Development of the innovative treatment using self iPS cell for acute liver failure
开发利用自身 iPS 细胞治疗急性肝衰竭的创新疗法
- 批准号:
21K08685 - 财政年份:2021
- 资助金额:
$ 1.6万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Pediatric Acute Liver Failure Immune Response Network (PALF IRN): Treatment for Immune Mediated Pathophysiology (TRIUMPH)
小儿急性肝衰竭免疫反应网络 (PALF IRN):免疫介导的病理生理学治疗 (TRIUMPH)
- 批准号:
10421290 - 财政年份:2021
- 资助金额:
$ 1.6万 - 项目类别: